Bain Capital and Kohlberg have completed a strategic investment in PCI Pharma Services, according to a news release.

Of course, the recent CBI action has triggered a debate on bringing the proposed National Pharmacy Commission Bill at the earliest as there are several loopholes in the present system and in the ...

Integrated, tech-forward platforms are going to define the next chapter of healthcare commercialization, and this merger puts ...

Thermo Fisher Scientific Inc. has expanded its strategic partnership with Sanofi to enable additional U.S. drug product manufacturing.

Catching up with Jon Maschmeyer, partner at Permira, to learn more about the growth strategy for Valeris, which formed from the Permira portfolio company PharmaCord and Odyssey Investment ...

In a move to bolster its drug manufacturing capabilities in the United States, Thermo Fisher has purchased a sterile ...

Find latest healthcare news from every corner of the globe at Reuters.com, your online source for breaking international news coverage.

Mubadala Investment Company ("Mubadala"), the Abu Dhabi based investment company, has entered into an agreement to make a significant reinvestment in PCI Pharma Services ("PCI"), a world-leading ...

Per the deal, Thermo Fisher will acquire Sanofi’s sterile drug product manufacturing facility in Ridgefield, NJ, to support ...